glp-1 home monitoring tools Introducing Insights GLP1-g insulation resistance test devices

The trend of combining therapies continues to gain momentum, with growing support for pairing GLP-1 receptor agonists and SGLT2 inhibitors

For nausea, eat smaller, more frequent meals, avoid fatty or spicy foods, and stay hydrated

In postmenopausal women, estrogen therapy has been associated with reductions in central adiposity and improvements in glucose metabolism independent of weight loss

Key findings (Vafaei et al., 2025): 30-50 mg/kg mirtazapine: dose-dependent seizure suppression Mediated by CB1/CB2 activation (proven by antagonist blockade) GABA-independent mechanism (distinct from benzodiazepines) Appetite/weight gain provides in-vivo functional validation of CB1 engagement The broader implication: Clinicians and researchers have been using ECS pharmacologyunknowinglyfor decades